166 related articles for article (PubMed ID: 17014060)
1. Effects of protease inhibitors on glucose tolerance, lipid metabolism, and body composition in children and adolescents infected with human immunodeficiency virus.
Ergun-Longmire B; Lin-Su K; Dunn AM; Chan L; Ham K; Sison C; Stavola J; Vogiatzi MG
Endocr Pract; 2006; 12(5):514-21. PubMed ID: 17014060
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.
Ruiz L; Negredo E; Domingo P; Paredes R; Francia E; Balagué M; Gel S; Bonjoch A; Fumaz CR; Johnston S; Romeu J; Lange J; Clotet B;
J Acquir Immune Defic Syndr; 2001 Jul; 27(3):229-36. PubMed ID: 11464141
[TBL] [Abstract][Full Text] [Related]
3. Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study.
Guaraldi G; Zona S; Orlando G; Carli F; Stentarelli C; Luzi K; Garlassi E; Menozzi M; Bagni P; Adorni F
Clin Drug Investig; 2011 Nov; 31(11):759-67. PubMed ID: 21919542
[TBL] [Abstract][Full Text] [Related]
4. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
[TBL] [Abstract][Full Text] [Related]
5. Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children.
Bitnun A; Sochett E; Babyn P; Holowka S; Stephens D; Read S; King SM
AIDS; 2003 Jun; 17(9):1319-27. PubMed ID: 12799553
[TBL] [Abstract][Full Text] [Related]
6. Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.
Negredo E; Ribalta J; Paredes R; Ferré R; Sirera G; Ruiz L; Salazar J; Reiss P; Masana L; Clotet B
AIDS; 2002 Jul; 16(10):1383-9. PubMed ID: 12131215
[TBL] [Abstract][Full Text] [Related]
7. Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy.
Estrada V; Serrano-Ríos M; Martínez Larrad MT; Villar NG; González López A; Téllez MJ; Fernández C
J Acquir Immune Defic Syndr; 2002 Jan; 29(1):32-40. PubMed ID: 11782587
[TBL] [Abstract][Full Text] [Related]
8. Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors.
Melvin AJ; Lennon S; Mohan KM; Purnell JQ
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1117-23. PubMed ID: 11522181
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study.
Petit JM; Duong M; Duvillard L; Piroth L; Grappin M; Verges B; Chavanet P; Brun JM; Portier H
Horm Metab Res; 2000 Sep; 32(9):367-72. PubMed ID: 11014386
[TBL] [Abstract][Full Text] [Related]
10. Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors.
Temple ME; Koranyi KI; Nahata MC
Ann Pharmacother; 2003 Sep; 37(9):1214-8. PubMed ID: 12921501
[TBL] [Abstract][Full Text] [Related]
11. Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults.
Blázquez D; Ramos-Amador JT; Saínz T; Mellado MJ; García-Ascaso M; De José MI; Rojo P; Navarro ML; Muñoz-Fernández MÁ; Saavedra J; Roa MA; Jiménez S; Beceiro J; Prieto L; Hortelano MG; González-Tomé MI
BMC Infect Dis; 2015 Mar; 15():119. PubMed ID: 25880777
[TBL] [Abstract][Full Text] [Related]
12. Association of adiponectin/leptin ratio with carbohydrate and lipid metabolism parameters in HIV-infected patients during antiretroviral therapy.
Tiliscan C; Arama V; Mihailescu R; Munteanu D; Iacob DG; Popescu C; Catana R; Negru A; Lobodan A; Arama SS
Endocr Res; 2018 Aug; 43(3):149-154. PubMed ID: 29451987
[TBL] [Abstract][Full Text] [Related]
13. Apoprotein c-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy.
Bonnet E; Ruidavets JB; Tuech J; Ferrières J; Collet X; Fauvel J; Massip P; Perret B
J Clin Endocrinol Metab; 2001 Jan; 86(1):296-302. PubMed ID: 11232015
[TBL] [Abstract][Full Text] [Related]
14. Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients.
Beatty G; Chu J; Kulkarni K; Lipshutz G; Khalili M; Abbasi F; Stansell J; Reaven GM
HIV Clin Trials; 2004; 5(6):383-91. PubMed ID: 15682351
[TBL] [Abstract][Full Text] [Related]
15. Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors.
Santiprabhob J; Chokephaibulkit K; Khantee P; Maleesatharn A; Phonrat B; Phongsamart W; Lapphra K; Wittawatmongkol O; Rungmaitree S; Tanchaweng S; Maturapat S; Lermankul W; Tungtrongchitr R
Cytokine; 2020 Dec; 136():155145. PubMed ID: 32920318
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidaemia and insulin resistance in vertically HIV-infected children and adolescents.
dos Reis LC; de Carvalho Rondó PH; de Sousa Marques HH; de Andrade SB
Trans R Soc Trop Med Hyg; 2011 Apr; 105(4):197-203. PubMed ID: 21371728
[TBL] [Abstract][Full Text] [Related]
17. Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART.
Tomazic J; Karner P; Vidmar L; Maticic M; Sharma PM; Janez A
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):99-105. PubMed ID: 16200335
[TBL] [Abstract][Full Text] [Related]
18. Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS.
Levy AR; McCandless L; Harrigan PR; Hogg RS; Bondy G; Iloeje UH; Mukherjee J; Montaner JS
Lipids Health Dis; 2005 Feb; 4():4. PubMed ID: 15705191
[TBL] [Abstract][Full Text] [Related]
19. Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine.
Fisac C; Fumero E; Crespo M; Roson B; Ferrer E; Virgili N; Ribera E; Gatell JM; Podzamczer D
AIDS; 2005 Jun; 19(9):917-25. PubMed ID: 15905672
[TBL] [Abstract][Full Text] [Related]
20. Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy.
Melvin AJ; Kang M; Hitti J; Livingston E; Cohn SE; Stocker V; Ross AC; Watts H; McComsey GA
Antivir Ther; 2008; 13(3):349-55. PubMed ID: 18572747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
